Drdgold Stock Revenue
Drdgold fundamentals help investors to digest information that contributes to Drdgold's financial success or failures. It also enables traders to predict the movement of Drdgold Pink Sheet. The fundamental analysis module provides a way to measure Drdgold's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Drdgold pink sheet.
Drdgold |
Drdgold Company Revenue Analysis
Drdgold's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Drdgold Revenue | 5.12 B |
Most of Drdgold's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Drdgold is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Drdgold reported 5.12 B of revenue. This is 34.87% lower than that of the Basic Materials sector and 235.93% higher than that of the Gold industry. The revenue for all United States stocks is 45.75% higher than that of the company.
Drdgold Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Drdgold's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Drdgold could also be used in its relative valuation, which is a method of valuing Drdgold by comparing valuation metrics of similar companies.Drdgold is currently under evaluation in revenue category among its peers.
Drdgold Fundamentals
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.24 % | |||
| Current Valuation | 433.63 M | |||
| Shares Outstanding | 857.98 M | |||
| Shares Owned By Insiders | 50.23 % | |||
| Shares Owned By Institutions | 10.67 % | |||
| Price To Earning | 0.59 X | |||
| Price To Book | 1.58 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 5.12 B | |||
| Gross Profit | 1.38 B | |||
| EBITDA | 1.8 B | |||
| Net Income | 1.12 B | |||
| Cash And Equivalents | 2.53 B | |||
| Cash Per Share | 29.44 X | |||
| Total Debt | 52.3 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 4.92 X | |||
| Book Value Per Share | 63.40 X | |||
| Cash Flow From Operations | 1.5 B | |||
| Earnings Per Share | 0.07 X | |||
| Number Of Employees | 943 | |||
| Beta | 1.19 | |||
| Market Capitalization | 674.43 M | |||
| Total Asset | 7.08 B | |||
| Retained Earnings | (2.98 B) | |||
| Working Capital | 287 M | |||
| Current Asset | 601 M | |||
| Current Liabilities | 314 M | |||
| Z Score | 7.2 | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 7.08 B | |||
| Last Dividend Paid | 6.0 |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Drdgold Pink Sheet
If you are still planning to invest in Drdgold check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Drdgold's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |